Telangana Pharma Hub Gets Centre Of Excellence Status is drawing significant interest across the industry.
The PRIP scheme, with an outlay of ?5,000 crore till FY 2030, supports R&D across the pharma–medtech lifecycle — from early research to product development and commercialisation.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →